marijuana stocks news

Form 8-K for LEXARIA CORP.


20-Jan-2016

Regulation FD Disclosure, Financial Statements and Exhibits

Item 7.01 Regulation FD Disclosure.A copy of the news release announcing Lexaria test results on nitric oxide filed as exhibit 99.1 to this current report and is hereby incorporated by reference.

 

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.Exhibit No. Description

99.1 News Release dated January 20, 2016


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

The Green Organic Dutchman Holdings Ltd. (TGOD.TO) (TGODF) Selects Shopify for Ecommerce Solution

The Green Organic Dutchman Selects Shopify for Ecommerce Solution The Green Organic…

Cara Therapeutics, Inc. (CARA) Announces No Modifications in Trial Size for Phase 2 Trial of Oral KORSUVA™

Cara Therapeutics Announces No Modifications in Trial Size for Phase 2 Trial…

Better Choice Company (BTTR) Closes $17.8M Insider-led Financing to Expand

Better Choice Closes $17.8M Insider-led Financing to Expand Its Rapidly Growing E-Commerce,…

$CARA to Webcast Presentation at 22nd Annual BioCentury Future Leaders in the Biotech Industry Conference

Cara Therapeutics to Webcast Presentation at 22nd Annual BioCentury Future Leaders in…